4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-25-008564
Options or other derivatives
- Chief Executive Officer acquired 9,761 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Climaco John M Chief Executive Officer | 2025-11-17 | Grant or award · Option to purchase common stock | +9,761 | 9,761 | D | ||
Loading xslF345X05/ownership.xml…